Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nurix Therapeutics Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Revenue
$77m
CAGR 3-Years
63%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$55B
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.8B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Revenue
$30.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.3B
CAGR 3-Years
16%
CAGR 5-Years
25%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.5B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
18%

Nurix Therapeutics Inc
Revenue Breakdown

Breakdown by Geography
Nurix Therapeutics Inc

Not Available

Breakdown by Segments
Nurix Therapeutics Inc

Total Revenue: 77m USD
100%
Collaboration Revenue: 57m USD
74%
License Revenue: 20m USD
26%

See Also

What is Nurix Therapeutics Inc's Revenue?
Revenue
77m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Revenue amounts to 77m USD.

What is Nurix Therapeutics Inc's Revenue growth rate?
Revenue CAGR 5Y
16%

Over the last year, the Revenue growth was 99%. The average annual Revenue growth rates for Nurix Therapeutics Inc have been 63% over the past three years , 16% over the past five years .

Back to Top